A highly purified gel electrophoretic fraction of murine leukemia virus (MuLV) can confer enhanced infectivity on MuLV derived from tissue culture and can protect MuLV from neutralization by specific antiserum. Of the known viral proteins tested, a purified electrophoretic fraction (14,000 daltons) is the only active fraction and seems to consist of the group-specific antigen I and an associated lipid moiety. The action of this fraction obtained from one type of MuLV is group-specific in that it can enhance and protect serologically different types of MuLV. The effect of this fraction is exerted on viruses and not on cells. MuLV derived from tumors was not enhanced by the fraction, but became amenable to its action after a single passage through tissue culture. Reconstruction experiments suggested that the fraction may consist of an exterior protein associated with some lipids. This complex, which apparently protrudes on the viral surface, is required for infectivity and shields the typespecific antigen containing the hemagglutinating site.Several of the murine leukemia virus (MuLV) proteins have recently been separated, isolated, and identified as distinct virus antigens (1-7). The availability of relatively specific, as well as complex, antisera has revealed in complement fixation and immunodiffusion tests several separate group-specific (gs) and one type-specific (v) antigen (6, 8). The new nomenclature based on purified antigen reactivity recognizes the following main antigens: IV, the major gs-antigen of the species-specific type previously described as gs-1; V, the gs-antigen also known as gs-3 shared by leukemia viruses of several mammalian species; III a lesser antigen; II, an antigen complex that contains both a gs-and type-specific determinants and hemagglutinating activity; I, a species-specific gs-antigen that can be lost after treatment with neuraminidase and phospholipase C; and finally component X, which could be identified as a virus-specific structure by complement fixation (6,(8)(9)(10) (80/20), by inoculation of a small volume (0.2 ml) of virus directly into a large volume (5 ml) of supernatant. Lytic-type lesions indicative of MuLV replication were scored as focus-inducing units (FIU) as described (12, 13).Antisera and Neutralization. A GLV-specific G-serum of high titer, "Old," obtained from F1 (WFu X BN) rats carrying syngeneic lymphomas induced by GLV, and an FLY or Rauscher leukemia virus (RLV)-specific antiserum produced in monkeys against plasma RLV, RM-serum, "Fink," were gifts from Drs. L. Old and M. Fink, respectively (1,14